Clinical trials: Early Latent Syphilis
Early Latent Syphilis, Primary Syphilis
Alternative Antibiotics for Syphilis
The Trep-AB clinical trial will test the efficacy of an investigational neuropenetrative drug, Linezolid (LZD), compared to standard treatment, Benzathine penicillin G (BPG), for early syphilis in humans.
- Conditions
- Early Latent Syphilis, Primary Syphilis, Secondary Syphilis
- Trial name
- NCT05069974
- Testing
- Linezolid 600 mg (post-interim), Benzathine Penicilllin G (post-interim)
- Where
- 11 sites in Spain, United Kingdom
- Volunteers
- 165 people
- Sponsor
- Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Syphilis, Primary Syphilis
Penicillin Therapeutic Drug Monitoring in the Treatment of Infectious Syphilis.
Syphilis is a sexually transmitted infection that causes genital sores and rash, but in some circumstances may result in more severe and unexpected symptoms.
- Conditions
- Syphilis, Primary Syphilis, Secondary Syphilis, Early-Latent Syphilis
- Trial name
- NCT01540227
- Testing
- Regular Treatment for Syphilis
- Where
- 3 sites in Canada
- Volunteers
- 25 people
- Sponsor
- Ottawa Hospital Research Institute
Early Syphilis, Latent, Serological Relapse After Treatment
Comparisons of Treatment Responses of Early Syphilis to Benzathine Penicillin G With or Without Doxycycline
This randomized controlled superiority study will be conducted during 2023-2025. The eligible participants are adult people living with HIV (PLWH) who are newly diagnosed with early syphilis.
- Trial name
- NCT06069141
- Testing
- Benzathine Penicillin G, Doxycycline Capsule
- Where
- 9 sites in Taiwan
- Volunteers
- 688 people
- Sponsor
- National Taiwan University Hospital